Literature DB >> 30054207

In situ detection of PR3-ANCA+ B cells and alterations in the variable region of immunoglobulin genes support a role of inflamed tissue in the emergence of auto-reactivity in granulomatosis with polyangiitis.

Gesche Weppner1, Olena Ohlei2, Christoph M Hammers3, Konstanze Holl-Ulrich4, Jan Voswinkel5, Julia Bischof3, Katrin Hasselbacher6, Gabriela Riemekasten1, Peter Lamprecht1, Saleh Ibrahim3, Christof Iking-Konert7, Andreas Recke3, Antje Müller8.   

Abstract

Circulating anti-neutrophilic cytoplasmic autoantibodies targeting proteinase 3 (PR3-ANCA) are a diagnostic and pathogenic hallmark of granulomatosis with polyangiitis (GPA). It is, however, incompletely understood if inflamed tissue supports presence or emergence of PR3-ANCA+ B cells. In search of such cells in inflamed tissue of GPA, immunofluorescence staining for IgG and a common PR3-ANCA idiotype (5/7 Id) was undertaken. Few 5/7 Id+/IgG+ B cells were detected in respiratory and kidney tissue of GPA. To gain more insight into surrogate markers possibly indicative of an anti-PR3-response, a meta-analysis comprising IGVH and IGVL genes derived from respiratory tract tissue of GPA (231 clones) was performed. Next generation sequencing-based IGHV genes derived from peripheral blood of healthy donors (244.353 clones) and previously published IGLV genes (148 clones) served as controls. Additionally, Ig genes of three murine and five known human monoclonal anti-PR3 antibodies were analyzed. Primary and probably secondary rearrangements led to altered VDJ usage and an extended complementarity determining region 3 (CDR3) of IGHV clones from GPA tissue. Selection against amino acid exchanges was prominent in the framework region of IGHV clones from GPA tissue. The comparison of V(D)J rearrangements and deduced amino acid sequences of the CDR3 yielded no identities and few similarities between clones derived from respiratory tissue of GPA and anti-PR3 antibodies, arguing against a presence of B cells that carry PR3-ANCA-prone Ig genes among the clones. In line with the scarcity of 5/7 Id+ B lymphocytes in GPA tissue, the results suggest that with respect to a local anti-PR3 response, methods detecting rare clones are required.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Granulomatosis with polyangiitis; IGHV gene; IGLV gene; Meta-analysis; PR3-ANCA

Mesh:

Substances:

Year:  2018        PMID: 30054207     DOI: 10.1016/j.jaut.2018.07.004

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  4 in total

Review 1.  [Granulomatous vasculitides and vasculitides with extravascular granulomatosis].

Authors:  Sabrina Arnold; Sebastian Klapa; Konstanze Holl-Ulrich; Antje Müller; Anja Kerstein-Stähle; Peter Lamprecht
Journal:  Z Rheumatol       Date:  2022-08-12       Impact factor: 1.530

Review 2.  Staphylococcus aureus Nasal Carriage and Autoimmune Diseases: From Pathogenic Mechanisms to Disease Susceptibility and Phenotype.

Authors:  Fulvia Ceccarelli; Carlo Perricone; Giulio Olivieri; Enrica Cipriano; Francesca Romana Spinelli; Guido Valesini; Fabrizio Conti
Journal:  Int J Mol Sci       Date:  2019-11-11       Impact factor: 5.923

Review 3.  Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases.

Authors:  Danqi Li; Yuchen Lou; Yamin Zhang; Si Liu; Jun Li; Juan Tao
Journal:  Theranostics       Date:  2021-03-13       Impact factor: 11.556

4.  Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis.

Authors:  Alvise Berti; Sophie Hillion; Amber M Hummel; Young Min Son; Nedra Chriti; Tobias Peikert; Eva M Carmona; Wayel H Abdulahad; Peter Heeringa; Kristina M Harris; E William St Clair; Paul Brunetta; Fernando C Fervenza; Carol A Langford; Cees Gm Kallenberg; Peter A Merkel; Paul A Monach; Philip Seo; Robert F Spiera; John H Stone; Guido Grandi; Jie Sun; Jacques-Olivier Pers; Ulrich Specks; Divi Cornec
Journal:  JCI Insight       Date:  2021-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.